Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Peltzer, Nieves ^a   Vanli, Güliz ^a   Yang, Jiang Yan ^a   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; FAS LIGAND; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MUTANT PROTEIN; PROTEIN BAD; PROTEIN KINASE B; SURVIVIN; BIRC5 PROTEIN, HUMAN; BIRC5 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MULTIPROTEIN COMPLEX; REPRESSOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; N FRAGMENT; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; ULTRAVIOLET B RADIATION; 129 MOUSE; ANIMAL; C57BL MOUSE; CYTOPLASM; DRUG EFFECTS; FIBROBLAST; GENETICS; HELA CELL LINE; METABOLISM; PANCREAS ISLET BETA CELL; RADIATION RESPONSE; TRANSGENIC MOUSE;

RAPTORES;

ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CELL DEATH; CYTOPLASM; FIBROBLASTS; HELA CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INSULIN-SECRETING CELLS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; P120 GTPASE ACTIVATING PROTEIN; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; RNA, MESSENGER; TOR SERINE-THREONINE KINASES;

EID: 84879511216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068123     Document Type: Article

References (63)

1. Yang J-Y, Michod D, Walicki J, Murphy BM, Kasibhatla S, et al. (2004) Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol Cell Biol 24: 10425-10436.
2. Newton K, Strasser A, (2003) Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev 17: 819-825.
3. Woo M, Hakem R, Furlonger C, Hakem A, Duncan GS, et al. (2003) Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat Immunol 4: 1016-1022.
4. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, et al. (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472: 319-324.
5. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA, (2002) Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99: 11025-11030.
6. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, et al. (2002) Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100: 4446-4453.
7. Miura M, Chen XD, Allen MR, Bi Y, Gronthos S, et al. (2004) A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 114: 1704-1713.
8. Droin N, Cathelin S, Jacquel A, Guery L, Garrido C, et al. (2008) A role for caspases in the differentiation of erythroid cells and macrophages. Biochimie 90: 416-422.
9. Yang J-Y, Michod D, Walicki J, Widmann C, (2004) Surviving the kiss of death. Biochem Pharmacol 68: 1027-1031.
10. Khalil H, Peltzer N, Walicki J, Yang JY, Dubuis G, et al. (2012) Caspase-3 protects stressed organs against cell death. Mol Cell Biol 32: 4523-4533.
11. Yang J-Y, Walicki J, Michod D, Dubuis G, Widmann C, (2005) Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157. Mol Biol Cell 16: 3511-3520.
12. Yang J-Y, Widmann C, (2001) Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol Cell Biol 21: 5346-5358.
13. Hers I, Vincent EE, Tavare JM, (2011) Akt signalling in health and disease. Cell Signal 23: 1515-1527.
14. Brazil DP, Yang ZZ, Hemmings BA, (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242.
15. Fayard E, Tintignac LA, Baudry A, Hemmings BA, (2005) Protein kinase B/Akt at a glance. J Cell Sci 118: 5675-5678.
16. Hu P, Han Z, Couvillon AD, Exton JH, (2004) Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J Biol Chem 279: 49420-49429.
17. Johnson NC, Dan HC, Cheng JQ, Kruk PA, (2004) BRCA1 185delAG mutation inhibits Akt-dependent, IAP-mediated caspase 3 inactivation in human ovarian surface epithelial cells. Exp Cell Res 298: 9-16.
18. Juntilla MM, Koretzky GA, (2008) Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 116: 104-110.
19. Yang J-Y, Widmann C, (2002) The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFκB activation. J Biol Chem 277: 14641-14646.
20. Yang JY, Walicki J, Jaccard E, Dubuis G, Bulat N, et al. (2009) Expression of the NH2-terminal fragment of RasGAP in pancreatic β-cells increases their resistance to stresses and protects mice from diabetes. Diabetes 58: 2596-2606.
21. Bulat N, Jaccard E, Peltzer N, Khalil H, Yang JY, et al. (2011) RasGAP-derived fragment N increases the resistance of beta cells towards apoptosis in NOD mice and delays the progression from mild to overt diabetes. PLoS ONE 6: e22609.
22. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, et al. (2006) Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proc Natl Acad Sci U S A 103: 5072-5077.
23. Yang J-Y, Walicki J, Abderrahmani A, Cornu M, Waeber G, et al. (2005) Expression of an uncleavable N-terminal RasGAP fragment in insulin-secreting cells increases their resistance toward apoptotic stimuli without affecting their glucose-induced insulin secretion. J Biol Chem 280: 32835-32842.
24. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168.
25. Hay N, Sonenberg N, (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
26. Hay N, (2005) The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183.
27. Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N, (2010) Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta 1804: 433-439.
28. Tomasoni R, Mondino A, (2011) The tuberous sclerosis complex: balancing proliferation and survival. Biochem Soc Trans 39: 466-471.
29. Youle RJ, Strasser A, (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
30. Strasser A, Cory S, Adams JM, (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30: 3667-3683.
31. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
32. Yue Z, Carvalho A, Xu Z, Yuan X, Cardinale S, et al. (2008) Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line. J Cell Biol 183: 279-296.
33. Stauber RH, Mann W, Knauer SK, (2007) Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67: 5999-6002.
34. Ruchaud S, Carmena M, Earnshaw WC, (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8: 798-812.
35. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, et al. (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23: 2825-2837.
36. Dohi T, Okada K, Xia F, Wilford CE, Samuel T, et al. (2004) An IAP-IAP complex inhibits apoptosis. J Biol Chem 279: 34087-34090.
37. Dan HC, Jiang K, Coppola D, Hamilton A, Nicosia SV, et al. (2004) Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis. Oncogene 23: 706-715.
38. Zhao P, Meng Q, Liu LZ, You YP, Liu N, et al. (2010) Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophys Res Commun 395: 219-224.
39. Annibaldi A, Michod D, Vanetta L, Cruchet S, Nicod P, et al. (2009) Role of the sub-cellular localization of RasGAP fragment N2 for its ability to sensitize cancer cells to genotoxin-induced apoptosis. Exp Cell Res 315: 2081-2091.
40. Li F, Altieri DC, (1999) The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 59: 3143-3151.
41. Li Y, Xie M, Yang J, Yang D, Deng R, et al. (2006) The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene 25: 3296-3306.
42. Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, et al. (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847-851.
43. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, et al. (2003) Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 23: 1428-1440.
44. Annibaldi A, Dousse A, Martin S, Tazi J, Widmann C, (2011) Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 3127-326 sequence does not involve G3BP1. PLoS One 6: e29024.
45. Jordan M, Schallhorn A, Wurm FM, (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24: 596-601.
46. Peltzer N, Bigliardi P, Widmann C, (2012) UV-B induces cytoplasmic survivin expression in mouse epidermis. J Dermatol Sci 67: 196-199.
47. Blommaart EF, Luiken JJ, Blommaart PJ, van Woerkom GM, Meijer AJ, (1995) Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J Biol Chem 270: 2320-2326.
48. Castedo M, Ferri KF, Kroemer G, (2002) Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ 9: 99-100.
49. Chen Y, Zheng Y, Foster DA, (2003) Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22: 3937-3942.
50. Gadir N, Jackson DN, Lee E, Foster DA, (2008) Defective TGF-beta signaling sensitizes human cancer cells to rapamycin. Oncogene 27: 1055-1062.
51. Chen Y, Rodrik V, Foster DA, (2005) Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene 24: 672-679.
52. Downward J, (1999) How BAD phosphorylation is good for survival. Nat Cell Biol 1: E33-E35.
53. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, et al. (2000) Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 60: 5988-5994.
54. Yin XM, (2006) Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369: 7-19.
55. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
56. Mandal M, Maggirwar SB, Sharma N, Kaufmann SH, Sun SC, et al. (1996) Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J Biol Chem 271: 30354-30359.
57. Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simoes-Wust AP, Yousefi S, et al. (2005) Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int J Cancer 117: 755-763.
58. Hu H, Li Z, Chen J, Wang D, Ma J, et al. (2010) P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells. Gut.
59. Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, et al. (2007) Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex. J Biol Chem 282: 26202-26209.
60. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, et al. (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22: 2729-2740.
61. Jiang Y, Saavedra HI, Holloway MP, Leone G, Altura RA, (2004) Aberrant regulation of survivin by the RB/E2F family of proteins. J Biol Chem 279: 40511-40520.
62. Connell CM, Colnaghi R, Wheatley SP, (2008) Nuclear survivin has reduced stability and is not cytoprotective. J Biol Chem 283: 3289-3296.
63. Li F, Altieri DC, (1999) Transcriptional analysis of human survivin gene expression. Biochem J 344 Pt 2: 305-311.